Source: International Congress 2016 – Smoking-related diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
İbrahim Koç (Gaziantep, Turkey), Ibrahim Koç, Funda Yalçin, Ahmet Ulusan. Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease. Eur Respir J 2016; 48: Suppl. 60, 4334

Member's Comments

No comment yet.

Related content which might interest you: Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Some gender features of the chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment Year: 2013 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes Source: Eur Respir J 2003; 21: 30S-35S Year: 2003 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products Year: 2015 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001